Related Experiment Videos
Primary spontaneous pneumothorax in men
I Z Abolnik1, I S Lossos, D Gillis
1Internal Medicine Department, Methodist Hospital Central, Methodist Hospitals of Memphis, Tennessee.
The American Journal of the Medical Sciences
|May 1, 1993
Summary
Primary spontaneous pneumothorax (PSP) affects military-aged men, with genetics and tall, thin builds being key risk factors. Recurrence is common, but surgery prevents it, and sclerosing agents are more effective than chest tubes for non-surgical treatment.
Area of Science:
- Thoracic Surgery
- Pulmonology
- Medical Research
Background:
- Primary spontaneous pneumothorax (PSP) is a significant medical concern, particularly in young adult males.
- Understanding PSP risk factors and treatment outcomes is crucial for effective patient management.
Purpose of the Study:
- To identify risk factors, clinical presentation, and long-term outcomes of PSP.
- To evaluate the efficacy of different treatment modalities for PSP recurrence.
Main Methods:
- Retrospective review of primary spontaneous pneumothorax (PSP) cases within the Israeli Defense Forces (IDF).
- Telephone interviews and medical record analysis of 286 male participants with PSP.
- Long-term follow-up averaging 107.2 months post-first PSP episode.
Main Results:
- A positive family history of PSP was reported by 11.5% of participants.
- A higher height-to-weight ratio correlated significantly with increased PSP episodes (regression coefficient 0.49).
- Recurrence rates were 38.3% with chest tube insertion alone versus 26.5% with sclerosing agents; no recurrences were noted after surgery.
Conclusions:
- PSP has a notable inherited component and is associated with asthenic body types.
- Chest tube insertion with intrapleural sclerosing agent instillation is recommended as the preferred non-surgical invasive treatment for PSP.
- PSP represents a significant health issue for military-aged men, necessitating further research and optimized treatment strategies.